Transjugular liver biopsy for liver damage after hematopoietic stem cell trasnplantation

Transjugular liver biopsy for liver damage after hematopoietic stem cell trasnplantation - Transjugular liver biopsy for liver damage after hematopoietic stem cell trasnplantation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017752

Enrollment

Registered

2015-05-31

Start date

2009-10-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver damage after hematopoietic stem cell transplantation

Interventions

Transjugular liver biopsy was underwent with Liver access and biopsy set (Cook Medical).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients after hematopoietic stem cell transplantation. 2. Age 16-65. 3. Liver damage.

Exclusion criteria

Exclusion criteria: 1. Obvious cause of liver damage. 2. Can be applied to percutaneous liver biopsy.

Design outcomes

Primary

Measure	Time frame
the rate of definitive diagnosis	—

Countries

Japan

Contacts

Public ContactHonda Akira

Univesity of Tokyo Hospital Hematology and Oncology

ahonda-spr@umin.org03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026